<code id='17E26CE0BA'></code><style id='17E26CE0BA'></style>
    • <acronym id='17E26CE0BA'></acronym>
      <center id='17E26CE0BA'><center id='17E26CE0BA'><tfoot id='17E26CE0BA'></tfoot></center><abbr id='17E26CE0BA'><dir id='17E26CE0BA'><tfoot id='17E26CE0BA'></tfoot><noframes id='17E26CE0BA'>

    • <optgroup id='17E26CE0BA'><strike id='17E26CE0BA'><sup id='17E26CE0BA'></sup></strike><code id='17E26CE0BA'></code></optgroup>
        1. <b id='17E26CE0BA'><label id='17E26CE0BA'><select id='17E26CE0BA'><dt id='17E26CE0BA'><span id='17E26CE0BA'></span></dt></select></label></b><u id='17E26CE0BA'></u>
          <i id='17E26CE0BA'><strike id='17E26CE0BA'><tt id='17E26CE0BA'><pre id='17E26CE0BA'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:3
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck
          Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

          EthanMiller/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbio

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Violet CEO on training clinicians to promote more inclusive care

          GaurangChoksiisthefounderandCEOofViolet,ahealthequityplatform.CourtesyGaurangChoksiPHOENIX,Ariz.—Gau